| Dr Aragam Krishnarao Subramanya, MD | |
|
320 Bolton St, 102, Marlborough, MA 01752-3980 | |
| (508) 481-7180 | |
| (508) 624-9374 |
| Full Name | Dr Aragam Krishnarao Subramanya |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 320 Bolton St, Marlborough, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205984614 | NPI | - | NPPES |
| B28039 | Other | MA | BLUE CROSS & BLUES HIELD |
| 034888 | Other | MA | ALL OTHER INSURANCES |
| 034888 | Other | MA | TUFTS HEALTH |
| 9720111 | Medicaid | MA | |
| 2000000134 | Other | MA | HARVARD PILGRIM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 34888 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aragam Krishnarao Subramanya, MD 320 Bolton St, 102, Marlborough, MA 01752-3980 Ph: (508) 481-7180 | Dr Aragam Krishnarao Subramanya, MD 320 Bolton St, 102, Marlborough, MA 01752-3980 Ph: (508) 481-7180 |
News Archive
New analysis from Frost & Sullivan, Strategic Analysis of the World Plant Molecular Farming Market, reveals that the biopharmaceutical market generated revenues of USD 45.0 billion in 2004. It is likely to reach USD 98.2 billion by 2011.
BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.
A team of researchers from Leicester has developed an innovative questionnaire which helps to shed light on the most common symptoms reported by people suffering from kidney disease.
Sequent Medical, Inc. announced today that it has initiated patient enrollment in an Investigational Device Exemption ("IDE") pivotal trial to evaluate the safety and effectiveness of the WEB Aneurysm Embolization System ("WEB").
Research presented today at Neuroscience 2009, the annual meeting of the Society for Neuroscience (SfN) and the world's largest source of emerging news about brain science and health, provide further insights into brain mechanisms, including those involved in music, social interaction, learning and memory.
› Verified 6 days ago
David B Wexler, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 157 Union St, Marlborough, MA 01752 Phone: 000-000-0000 |